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ABSTRACT
Objective Envenomation by Mesobuthus tamulus
scorpionstingcanresultinseriouscardiovasculareffects.
Scorpion antivenom is a specific treatment for scorpion
sting. Evidence for the benefit of scorpion antivenom and
its efficacy compared with that of commonly used
vasodilators, such as prazosin, is scarce. We assessed
the efficacy of prazosin combined with scorpion
antivenom, compared with prazosin alone, in individuals
with autonomic storm caused by scorpion sting.
Design Prospective, open label randomised controlled
trial.
Setting General hospital inpatients (Bawaskar Hospital
and Research Centre Mahad Dist-Raigad Maharashtra,
India).
Participants Seventy patients with grade 2 scorpion
envenomation, older than six months, with no
cardiorespiratory or central nervous system
abnormalities.
Intervention Scorpion antivenom plus prazosin (n=35) or
prazosin alone (n=35) assigned by block randomisation.
Treatment was not masked. Analysis was by intention to
treat.
Main outcome measures The primary end point was the
proportion of patients achieving resolution of the clinical
syndrome (sweating, salivation, cool extremities,
priapism, hypertension or hypotension, tachycardia) 10
hours after administration of study drugs. Secondary end
points were time required for complete resolution of
clinical syndrome, prevention of deterioration to higher
grade, doses of prazosin required overall and within 10
hours, and adverse events. The study protocol was
approved by the independent ethics committee of
Mumbai.
Results Mean (SD) recovery times in hours for the
prazosin plus scorpion antivenom group compared with
the prazosin alone groups were: sweating 3 (1.1) v 6.6
(2.6);salivation1.9(0.9)v3(1.9);priapism4.7(1.5)v9.4
(1.5). Mean (SD) doses of prazosin in the groups were 2
(2.3) and 4 (3.5), respectively. 32 patients (91.4%, 95%
confidence interval 76.9% to 97.8%) in the prazosin plus
antivenom group showed complete resolution of the
clinical syndrome within 10 hours of administration of
treatment compared with eight patients in the prazosin
group (22.9%, 11.8% to 39.3%). Patients from the
antivenom plus prazosin group recovered earlier (mean 8
hours, 95% CI 6.5 to 9.5) than those in the control group
(17.7 hours, 15.4 to 19.9; mean difference −9.7 hours,
−6.9 to −12.4). The number of patients whose condition
deteriorated to a higher grade was similar in both groups
(antivenomplusprazosinfourof35,prazosinalonefiveof
35). Hypotension was reported in fewer patients in the
antivenom plus prazosin group (12 of 35, 34.3%) than in
the prazosin group (19 of 35, 54.3%), but the difference
was not statistically significant. No difference was noted
in change in blood pressure and pulse rate over time
between two groups.
Conclusion Recovery from scorpion sting is hastened by
simultaneous administration of scorpion antivenom plus
prazosin compared with prazosin alone.
Trial registration number CTRI/2010/091/000584
(Clinical Trials Registry India).
INTRODUCTION
Scorpion sting can pose a life threatening acute medi-
cal emergency and is a neglected public health pro-
blem in tropical and sub-tropical countries, especially
in North Africa, the Middle East, Latin America, and
India.Mesobuthustamulus,anIndianredscorpion,isthe
tmost lethal species of the Buthidae family in India.
1 Its
venom delays the closing of neuronal sodium chan-
nels, resulting in “autonomic storm” owing to sudden
pouringofendogenouscatecholamineintothecircula-
tion. Autonomic storm is characterised by transient
parasympathetic and prolonged sympathetic
stimulation.
2-5 Similar cardiovascular manifestations
arereportedindifferentspeciesofscorpions.
6Morbid-
ity and mortality due to scorpion sting result from
acute refractory pulmonary oedema, cardiogenic
shock, and multiorgan failure.
5 Opinions differ about
thecorrecttreatmentforscorpionsting.Inthepastvar-
iousregimens,includingalyticcocktail,
7insulin,
8atro-
pine,βblocker,nifedipine,
9andcaptopril
10havefailed
Bawaskar Hospital and Research
Centre, Mahad, Dist-Raigad,
Maharashtra, India 402301
Correspondence to: H S Bawaskar
himmatbawaskar@rediffmail.com
Cite this as: BMJ 2010;341:c7136
doi:10.1136/bmj.c7136
BMJ | ONLINE FIRST | bmj.com page 1 of 8toreducemorbidityandmortality,butsincetheadvent
of the α1 blocker prazosin the fatality rate has been
reduced to 1%.
1112
Scorpion antivenom is a specific antidote capable of
neutralising circulating venom toxins if administered
soon after sting; it is widely used and believed to be
effective by experienced doctors in Mexico, Brazil,
Venezuela, Tunisia, and Iran.
13-17 Serotherapy has
beenamatterofdebateandcontroversyduringthepast
decade.
18-21Whethertheantivenomcanreversethecar-
diac pathophysiological effects of scorpion venom is
uncertain. Several studies have shown that antivenom
does not alleviate haemodynamic changes or cardio-
genic pulmonary oedema, or prevent death
1922 and
the outcome was the same for victims treated with anti-
venom and those treated without antivenom.
918 De
Rezende and colleagues found that although venom
antigen in plasma from people who had been stung by
a scorpion was not detected one hour after antivenom
therapy, and pain and agitation disappeared within a
few hours, patients with pulmonary oedema recovered
only 48 hours after serotherapy.
23
Since 2002, monospecific F(ab)2 antivenom serum
prepared by immunising horses has been available for
clinical use from Haffkine Biopharma Mumbai. Meso-
buthus tamulus is common in the western Maharashtra,
Saurashtra, Kerala, Andra Pradesh, Tamil Naidu, and
Karnataka states of India where morbidity and mortal-
ity due to stinging have been reported.
7-1024 Prazosin is
widely used for the management of Mesobuthus tamulus
sting.
111225-30 We did a prospective, randomised trial of
scorpionantivenomplusprazosinversusprazosinalone
in the treatment of severe Mesobuthus tamulus sting.
PATIENTS AND METHODS
Trial design
This study and trial were done without the help of any
funding agency. Anti-scorpion antivenom was pur-
chased from Haffkine Biopharma Mumbai and given
to participants in this trial. We proposed to include
people admitted with scorpion sting over one year,
between March 2009 and February 2010. This was a
randomised (1:1 allocation ratio), parallel group, open
label, controlled trial conducted at Bawaskar Hospital
inMahad,aregionofIndiawithapopulationof20000
, situated 180 km south of Mumbai on the Mumbai-
Goa highway. An independent data and safety moni-
toring board monitored the trial and had access to the
alldata.Statisticalanalysiswasdonebya statisticianin
collaboration with the investigators. The study design
was approved by the independent ethics committee of
BYL Medical College Mumbai (IEC/08/39) and all
participants provided written informed consent.
Sample size
Theprimaryefficacyvariablewasthetimerequiredfor
recoveryaftervenomousscorpionsting.Weestimated
that 35 patients in each group would be required to
achieve80%power;α=0.05todetectameandifference
of four hours in the recovery time between the groups,
assuming a mean recovery time of 10 hours (SD 2.5
hours) in the antivenom plus prazosin group and 14
(SD 3) hours for the prazosin alone group.
Randomisation
A statistician generated the sequentially numbered
randomisation list with random block sizes of 4 4 2 4
4 6 2 4 6 6 6 8 4 8 2 using www.randomisation.com.
Thisprocesscanbereproducedbyusingseed22491(6
March 2009). This randomisation sequence was con-
cealed by using sequentially numbered, opaque,
sealed,andstapledenvelopes.Envelopeswereopened
alternately by HSB or PHB after an eligible patient
consented to take part in the trial and patients were
allocated according to the randomisation label inside
the envelope.
Statistical methods
Demographic factors and clinical characteristics were
summarised as counts (percentages) for categorical
variablesandasmean(standarddeviation;SD)fornor-
mally distributed continuous variables. All patients
who had been randomly assigned to a treatment
group were included in the intention-to-treat analyses.
The groups were compared using χ
2 test or Fisher’s
exact test for categorical variables, unpaired t test for
normally distributed continuous variables, and Mann-
WhitneyUtestforothercontinuousvariables.Weana-
lysed results with SPSS 17 software. Blood pressure
and pulse rate were measured at different time points
and were repeated factors, and treatment group was
included as a between-participant measure. α was set
at 0.05. We used the Greenhouse-Geisser P value.
Patients
Between March 2009 and February 2010 we recruited
patients who reported to Bawaskar Hospital and
Mahad research centre after being stung by Mesobuthus
tamulus (fig 1).
24631
Inclusion and exclusion criteria
Patients were eligible for enrolment if they reported to
hospitalwithMesobuthustamulusstingofclinicalgrade2
severity,withanintervaloflessthansixhoursbetween
sting and hospital admission, and were older than six
months. Mesobuthus tamulus sting was confirmed if the
victim or bystander had seen a red scorpion, had
Fig 1 | Indian red scorpion (Mesobuthus tamulus)
RESEARCH
page 2 of 8 BMJ | ONLINE FIRST | bmj.combrought in the killed specimen, or recognised the
hospital’s preserved specimen. In this way we made
sure that Mesobuthus tamulus was not confused with
Palamneus gravimanus, a larger scorpion that is less
lethal and causes only severe local pain without sys-
temic involvement or transient reversible cardio-
vascular effects.
132 Major exclusion criteria were:
patient reporting six hours after sting, pregnant
women, history of taking prazosin or antivenom, his-
toryofbronchialasthma,historyofallergicreactionto
foreign serum, and refusal to give consent.
Written informed consent was obtained in the local
language. For illiterate adults, a literate relative of the
patient read the statement out loud to them and con-
sent was obtained by thumb impression witnessed by
the relative. Parent’s consent was obtained for minor
children. The study protocol was approved by the
independentethicscommitteeofMumbai(registration
number 1433/1999G.B.B.S.D, IEC/08/39). All peo-
ple admitted with scorpion sting between March
2009 to February 2010 were insured by the Oriental
Insurance Company Limited clinical trial liability
cover policy No 111600/48/2009/227.
Evaluation of clinical grade
Casesare gradedaccordingtoseverityofclinicalman-
ifestations on arrival at hospital (box). Severity of
clinical manifestations, morbidity, and mortality
depend on the time lapsed between sting and hospital
admission, as well as the grade of a case on
arrival.
59183334
Patients with grade 2 signs and symptoms were
includedinthepresentstudy.Aftergivingwrittencon-
sent, all eligible patients were examined by one of the
twoauthorsandbaselinedatawererecordedonastan-
dard form. Data included age, sex, time between sting
and hospital admission, and history of any medication
before admission, vomiting soon after sting, or para-
esthesia (tingling and numbness in the perioral region,
or sometimes reported by the patient to be felt all over
the body).
One of the authorssat by the side of the patientsand
closely clinically examined them for signs and symp-
toms of systemic manifestations: presence of profuse
sweating all over the body, ropey salivation, priapism
in men, heart murmur, coolness of the extremities.
Blood pressure, heart rate, cardiac arrhythmias,
respiratory rate, and oxygen saturation were moni-
tored on a multipara monitor. These findings were
noted on admission at 00.00, at 30 minutes, and at 1,
2, 4, 6, 8, 10, 14, 18, and 24 hours. Subsequent
improvement or deteriorations to grade 3 or 4 were
closely followed by the author who examined the
patienton arrival. Bloodwas collectedfrom all partici-
pants on admission for measurement of haemoglobin,
white cell count, and creatine kinase-MB. A 12 lead
electrocardiogram (ECG) was done on arrival, after
six hours, and before discharge.
Study treatments
Mesobuthus tamulus is not the only venomous scorpion
in the state of western Maharashtra, but it may be the
only dangerously venomous scorpion in the Mahad
area.
2425 Haffkine Biopharma (Mumbai) has been
manufacturing monovalent anti-scorpion venom
serum F(ab)2 against Mesobuthus tamulus since 1997
and it has been available for clinical use in a rural set-
ting since 2002. Studies conducted at different times
show that the antivenom is potent; 1 mL of reconsti-
tutedanti-scorpionvenomserumneutralised1.2mgof
Indian red scorpion venom by intravenous route in an
in vivo study in mice.
35 The maximum volume of
venominjectedinonestingbytheIndianredscorpion
is1.5mg,andeachmLofantivenomiscapableofneu-
tralising 1.2 to 1.5 mg of venom.
36
A single 30 mL dose of Haffkine Biopharma mono-
valent antivenom (batch no SS811001, manufacturing
date November 2008, expiry date April 2013) was
added to 100 mL of normal saline, which was infused
intravenouslyover30minutesirrespectiveofpatient’s
age. During infusion the patient was closely observed
forreactiontotheserumintheformofsuddenonsetof
vomiting, urticaria, hypotension,tachycardia, bronch-
ospasm, angioneurotic oedema, or anaphylaxis.
Oral prazosin (batch no ML.NH 138 batch no GK
60372 manufactured 04/2006, expiry 03/2011, and
ML.NH 138 batch no GK 80282 manufactured 02/
Evaluation of clinical grade of scorpion sting on arrival at hospital
Grade 1: severe,excruciatinglocalpainat thestingsite radiatingalongwithcorresponding
dermatomes, mild local oedema with sweating at the sting site, without systemic
involvement
Grade2:signsandsymptomsofautonomicstormcharacterisedbyacetylcholineexcessor
parasympathetic stimulation (vomiting, profuse sweating from all over body, ropey
salivation, bradycardia, premature ventricular contraction, hypotension, priapism in men)
and sympathetic stimulation (hypertension withblood pressure >140/90,tachycardia with
heart rate >120 per minute, cold extremities, transient systolic murmur).
Grade 3: cold extremities, tachycardia, hypotension or hypertension with pulmonary
oedema (respiratory rate >24 per minute, basal rales or crackles in lungs).
Grade 4: tachycardia, hypotension with or without pulmonary oedema with warm
extremities (warm shock).
Table 1 |Distribution of patients with scorpion sting by month
Month
Prazosin
(n=35)
Prazosin plus antivenom
(n=35)
January 4 3
February 2 2
March 2 2
April 1 2
May 6 4
June 1 1
August 0 1
September 3 4
October 7 5
November 5 6
December 4 5
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children up age 18 years and 500 µg in adults. The
same dose was repeated at intervals of 3 hours until
the extremities were cold. Similar doses were adminis-
tered in both randomisation groups.
Dehydration owing to vomiting and sweating was
correctedbyintravenouscrystalloidsolution.Thepra-
zosin treated group required longer duration and lar-
ger volumes of intravenous crystalloid solution than
the antivenom plus prazosin group. Patients who
developed grade 3 and 4 symptoms were transferred
to the intensive care unit. Before discharge all partici-
pants were immunised for tetanus.
Outcomes
The primary end point was the proportion of patients
achievingresolutionofthegrade2clinicalsyndromeat
the end of 10 hours after administration of the study
drugs and prevention of deterioration to grade 3 and
4.
182137 Secondary end points were time required for
complete resolution of clinical syndrome, prevention
of deterioration to higher grade, doses of prazosin
required within 10 hours and overall, and adverse
events.
RESULTS
Figure 2 shows the trial profile. We screened 116
patients admitted with scorpion sting for eligibility. Of
72 eligible patients, 70 were enrolled in the study; 35
were randomly allocated to prazosin alone and 35 to
prazosin plus antivenom. All patients completed treat-
ment in the group of allocation and none was lost to
follow-up. We analysed end points according to group
of allocation. Patients were recruited between March
2009 and February 2010 (table 1). We stopped recruit-
ing patients after achieving the required sample size.
The two groups were similar in demographic and
clinical characteristics at baseline (table 2). Mean
time between scorpion sting and arrival at hospital
and presenting symptoms were also similar between
the groups.
Table 3 shows recovery time for clinical signs and
symptomsinthetwogroups.Thetreatingdoctorsactu-
allysatbythesideofpatientsandnotedthedurationof
profusesweatingandflowingofsalivafromthecorners
of the mouth. They repeatedly felt the palm and sole
fortemperature.Priapismwasnotedevery15minutes.
Thirty-twopatients(91.4%,95%confidence interval
76.9% to 97.8%) on prazosin plus antivenom showed
completeresolutionoftheclinicalsyndromewithin10
hours of administration of treatment, compared with
eight patients (22.9%, 11.8% to 39.3%) in the prazosin
group; P<0.001 (table 4). The mean time required for
clearing of syndrome and recovery in the antivenom
plus prazosin group was 8.0 hours (95% confidence
interval 6.5 to 9.5), which was significantly shorter
(mean difference −9.7 hours, −6.9 to −12.4) than for
those treated only with prazosin (17.7 hours, 15.4 to
19.9;P<0.001).Themedianrecoverytimeforpatients
treatedwithantivenomplusprazosin(7hours)wassig-
nificantly less than that for patients treated with only
prazosin (18 hours; P<.0.001).
Patients in the antivenom plus prazosin group
required significantly (P<0.001) fewer doses of prazo-
sin (mean 2.3, 95% confidence interval 2.1 to 2.5) than
the prazosin group (mean doses 4.4, 95% CI 4.0 to 4;
mean difference −2.0, 95% CI −2.5 to 1.6). Fewer
patients in the antivenom plus prazosin group (12/35,
34.3%)developedhypotensionthanthoseintheprazo-
sin only group (19/35, 54.3%), but this difference was
not statistically significant (P=0.092, tables 3 and 4).
Laboratory values for haemoglobin, white cell
count, and creatine kinase-MB were similar between
the groups (table 5).
Both groups showed a significant (P<0.001) decline
in blood pressure (mean arterial pressure) from the
reading on admission (table 3). The pattern of
improvement was similar in both groups (P=0.838);
the difference between groups was non-significant
(P=0.982). Patients with hypotension recovered after
treatment with intravenous crystalloid solution.
Table 2 |Demographic and baseline clinical data
Prazosin (n=35)
Prazosin plus
antivenom (n=35)
Mean (SD) age in years 32.4 (15.7) 31.1 (21.1)
Sex
Male 24 (68.6%) 27 (77.1%)
Female 11 (31.4%) 8 (22.9%)
Children <18 years
Boys 5(26.3%) 9(47.3%)
Girls 2 (10.5%) 3(15.7%)
Mean (SD) time between
sting and admission
94.7 (43.9) 115.3 (66)
Vomiting 29 (82.9%) 29 (82.9%)
Paraesthesia 22 (62.9%) 23 (65.7%)
Sweating 34 (97.1%) 35 (100 %)
Salivation 25 (71.4%) 30 (85.7%)
Cold extremities 34 (97.1%) 35 (100%)
Priapism 14 /24 (58.3%) 17/ 27 (62.9%)
Bradycardia 10 (28.6%) 10 (28.6%)
Transient systolicmurmur 17 (48.6%) 19 (54.3%)
Table 3 |Recovery time for clinical syndrome
Clinical sign
Prazosin
(n=35)
Prazosin plus
antivenom
(n=35) P
Sweating, mean
(SD) hours
6.6 (2.6) 3 (1.1) <0.001
Salivation, mean
(SD) hours
3.0 (1.9) 1.9 (.9) 0.008
Priapism, mean
(SD) hours
9.4 (1.5) (n=24) 4.7 (1.5) (n=27) <0.001
Cold extremities,
mean (SD) hours
17.3 (6.6) 8.5 (5.3) <0.001
Number (%) with
hypotension
19 (54.3) 12 (34.3) <0.001
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venom, size of scorpion, season, age of victim, and
time betweenstingand hospitaladmission.Nineparti-
cipants (six children and three adults) deteriorated to
grade 3 (five from the prazosin group and three from
prazosin plus antivenom group) or grade 4 (one from
the prazosin plus antivenom group). They all reported
more than 130 minutes between sting and admission
and had mean systolic and diastolic blood pressure of
159 mm Hg and 105 mm Hg, respectively. Three of
these patients had a heart rate of <60 beats per minute
and six had a rate of >110 beats per minute. All nine
patients had repeated projectile vomiting and vomited
their initial dose of oral prazosin(injectable prazosinis
not available in India) so that their repeated first dose
was received 60 minutes late. All of them had persis-
tently raised blood pressure. The difference between
the groups was not statistically significant (P>0.999).
The patients who deteriorated to grade 3 recovered
after treatment with nasal oxygen, intravenous amino-
phylline,anddobutaminedrip.Thepatientwhosecon-
dition deteriorated to grade 4 was a 13 year girl who
wasstungontheleftfootbyascorpionat10pm.Ared
scorpion was found in her bedding and was killed.
Soon after the sting she vomited twice, profusely
sweated, salivated, and had paraesthesia around the
mouth.Shereportedtothehospitalat3am.Onarrival
herbloodpressurewas140/104andheartrate128;she
had grade 3/6 systolic murmur, cold extremities,
sweating, and absent salivation. Total white cell count
was 23,thin.000 and creatine kinase-MB was 62. She
was given 30 mL antivenom and 500 µg prazosin.
She developed marked tachycardia (heart rate 170
beats per minute) and warm extremities with blood
pressure 95/70 mm Hg and pulmonary oedema
(grade 4). She was given nasal oxygen, dobutamine
15 µg /kg/minute was raised to 20 µg, and oxygen
saturation was maintained by non-invasive ventilator
for 24 hours in intensive care.
DISCUSSION
We found that in patients treated for scorpion sting
with scorpion antivenom and prazosin incidences of
improvement and deterioration were similar to those
in patients treated with prazosin alone, and the addi-
tion of antivenom hastened recovery.
Previous studies
Stimulation of α receptors has an important role in the
pathogenesis of venomous scorpion sting.
613 In
experimentalstudies,themajorphysiologicalabnorm-
ality is stimulation of peripheral α1 adrenergic recep-
torsby venomleadingtobloodpressureresponse.For
this reason prazosin, an α receptor blocker, has been
successfully used to reverse toxicity and improve
survival.
31112 By blocking α1 receptors, prazosin
reduces preload and left ventricular impendence with-
out raising heart rate.
9 Prazosin is a simple pharmaco-
logical and physiological antidote to venom actions
that is easily available in rural settings
9 making it the
standard first line management.
1112 Of 619 patients
with severe envenomation by Mesobuthus tamulus
admitted at Mahad, hypertension was noted in 55%,
pulmonaryoedemain27%,tachycardiawithhypoten-
sionin 18%; all recovered withoral prazosin.
25 Similar
beneficial effects of prazosin have been reported from
otherstatesofIndia,
726SaudiArabia,
12andTurkey.
2729
Impressive reductions in mortality from Mesobuthus
tamulus sting have also been observed with the use of
prazosin; from 26% in 1961 to 6% in 1980, and less
than1%at present.
11Inregionswherevenomousscor-
pion sting is endemic, prazosin is a “darling” among
the drugs kept ready in the outpatient department
emergency tray; consultants in these areas even carry
two tablets in their bags.
38 Several specific scorpion
antivenoms are available but their efficacy is
uncertain.
1819 Ancillary treatment with vasodilators is
crucial in severely envenomed patients.
539
Scorpion antivenom has been available for clinical
use in India since 2002, but it is always in short supply
and not easily available in pharmacies, whereas prazo-
sin is freely available.
3340 Our experience of severe
scorpion sting cases since 1977 shows that mortality
canbedramaticallyreducedevenintheabsenceofanti
venom.
1112202629Althoughtheregimenincludingscor-
pion antivenom hastens recovery it is not
mandatory.
3940 Species specific antivenom is needed
toneutralisethecirculatingvenom;however,prazosin,
by antagonising sympathetic overactivity and correct-
ing deranged metabolism, is effective against enveno-
mationbydifferentscorpionspecies.
712161719Insevere
scorpion envenomation the dose of antivenom
required is much higher than that noted in an experi-
mental animal study.
3541 The scorpion stinger by
which venom is injected is short and sharp, 3-4 mm
Table 4 |Comparison of endpoints between the groups
End point
Prazosin plus
antivenom
(n=35)
Prazosin
(n=35)
Mean difference
(95% CI) P
Clearingofsyndromewithin10hours 32 (91.4%) 8 (22.8%) 68.5% (51.8 to 85.2) <0.001
Meanrecoverytime,hours(95%CI) 8 (6.5 to 9.5) 17.7 (15.4 to 19.9) −9.7 (−6.9 to 12.4) <0.001
Deterioration to grade 3/4 4 (11.4%) 5 (14.3%) −2.9%(−18.5to12.8) >0.999
Mean prazosin dose (95% CI) 2.3 (2.1 to 2.5) 4.4 (4.0 to 4.8) −2.0 (−2.5 to −1.6) <0.001
Total patients (n=116)
Patients randomised (n=70)
Prazosin (n=35) Antivenom + prazosin (n=35)
Completed trial (n=35) Completed trial (n=35)
Excluded (n=46):
  Grade 1 (n=44)
  Grade 4 (n=1)
  Pulmonary oedema (n=1)
Fig 2 | Trial profile
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full thicknessofhumanskinis1.5-4mm). Skincircula-
tion is sluggish and normally remains quiescent. Soon
afterstingingtherapidlyabsorbedvenomevokesauto-
nomic storm owing to sudden pouring of endogenous
catecholamineintothecirculation.α1receptorsare sti-
mulatedbythecirculatingcatecholamine,causingcold
skin as a result of vasoconstriction, which further
arrests the absorption of venom from the sting site.
Toxicokinetic studies in rabbits showed that scorpion
venomwasrapidlytakenupbyorgansandtissues,with
anestimated halflifeof twotosix minutes aftervenom
injection.
6
Moreover small doses of scorpion antivenom (such
asthe 10 mLdose usedina previousreportof 25 cases
from Mahad) have not been effective in preventing
morbidity and mortality caused by Mesobuthus tamulus
sting.Thisledustoconcludethattheroleofantivenom
inseverescorpionstingneededtobere-examinedand
that prazosin is the standard of care to overcome the
autonomic storm.
3738
Strength and limitations
We are not aware of any previous randomised con-
trolledtrials comparing the usefulness ofmono-specific
F(Ab)2 scorpion antivenom plus prazosin against pra-
zosinaloneinseverescorpionstingbyMesobuthustamu-
lus.Thenumberofcasesofenvenomingpeaksinthehot
monthsoftheyear,MayandOctober(table 1)because
ofincreasedagriculturalactivities.Menaremoreprone
totheseaccidentsowingtogreaterenvironmentalexpo-
sure (table 2). Twenty eight percentofthe study popu-
lation were younger than 18 years. Our findings in
relation to a substantial number of patients with grade
2 envenomation included in this study support a firm
conclusion about the efficacy of antivenom plus prazo-
sin in victims reporting within six hours of sting with
systemic involvement. Cases of grade 3 and grade 4
envenomation were not included in the present study,
as required by the ethics committee. Large randomised
trials including victims with grade 3 and 4 envenoma-
tion will be needed to demonstrate the effect of anti-
venom and prazosin on end points such as survival.
Thisstudywasnotblindedandtheprimaryoutcome
was evaluated by study investigators, albeit investiga-
tors with extensive clinical experience with scorpion
sting.
191120253334 The determination of the point at
which symptoms disappeared was thus subjective,
butwethinkthatthiswasaclinicallyrelevantandprag-
matic way of judging the effects of treatment in a trial
carried out in challenging circumstances with
restricted resources in a rural setting in India.
Scorpion venom evokes transient parasympathetic
and prolonged sympathetic stimulation. The presence
of clinical signs and symptoms of excess acetylcholine
indicate the presence of active free circulating venom
in the blood, which can be neutralised by antivenom.
Thesympatheticsignssuggestaftereffectsofvenomon
the sympathetic system, which are unresponsive to
antivenom but reversible with prazosin. Moreover
morbidity and mortality due to envenoming are
caused by sympathetic overstimulation and not para-
sympathetic stimulation.
1-411 Thus, early administra-
tion of antivenom in a stage of acetylcholine excess
and prazosin to counteract the sympathetic and meta-
bolic effects may be synergistic in enhancing
recovery.
1-410121517 On arrival, absence of sweating
and salivation that was present before reporting to the
hospital suggests that venom has already reached the
target site of action and is not accessible to the admin-
istration of antivenom,
22 as in our patient who deterio-
rated to grade 4.
Total doses of prazosin required were significantly
lower in the antivenom plus prazosin group than in
the prazosin alone group, suggesting that timely
administration of scorpion antivenom leads to rapid
neutralisation of circulating venom, resulting in mini-
mum venom available for neuronal sodium channel
activation. Amelioration of parasympathetic stimula-
tion (sweating, salivation, arrhythmias) by antivenom
may have accounted for the lower incidence of hypo-
tension in the antivenom plus prazosin group. Leuco-
cytosis and raised cardiac enzymes were suggestive of
the release of cytokines such as interleukin-6.
2238
No participant had a mild or severe reaction to anti-
venom. High circulating catecholamines induced by
venom prevent a reaction to antivenom and act as a
prophylaxis against anaphylaxis.
42 Administration of
the minimum first dose of prazosin prevented the
development of the first dose phenomenon.
43
Owing to unavailability of an ELISA test for detec-
tion of venom antigen and antivenom in blood we
could not perform a correlation with clinical manifes-
tations. Facilities for analysis of serum catecholamine
levels are not available at Mahad. We could not enrol
patients with grade 3 and 4 severe scorpion stings
owing to restriction by the ethics committee. With-
holding the lifesaving drug prazosin would be unethi-
calin alifethreateningsituation; henceit wasincluded
in both the arms of the trial and no placebo group was
included.
Conclusions and policy implications
Early administration of antivenom within six hours of
sting in addition to prazosin hastened the recovery and
shortened the hospital stay in a rural setting. Although
the rapid recoveryinpatientstreated withantivenomis
anadvantage,thetotalcostoftreatmentwithantivenom
approachesamonth’ssalaryforalabourerintheregion
—10mLofantivenomcostsRs350(£4.97,€5.82,$7.77)
—while the cost of 10 tablets of 1 mg prazosin is Rs32
(£0.49,€0.58,$0.77).Thedoseofprazosinadministered
Table 5 |Laboratory investigations. Data are mean (SD)
Laboratory investigation
Prazosin
(n=35)
Prazosin plus antivenom
(n=35) P
White blood cells (×10
9/L) 16.09 (3.87) 15.48 (4.08) 0.522
Creatine kinase-MB (U/L) 60.1 (23.5) 51.6 (14.9) 0.074
Haemoglobin (g/L) 12.3 (20) 12.4 (20) 0.840
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Administration of prazosin at an interval of three hours
prevented development of pulmonary oedema and led
to rapid recovery as reported previously.
33 The results
ofthepresentstudywouldbeapplicableinsettingssuch
asprimaryhealthcentres,wherethemajorityofthevic-
tims first present.
1 Scorpion sting is a potentially life
threatening time limiting acute medical emergency,
hence it would be unethical to withhold the standard
treatment for want of a scientific trial.
33
Despite much experience of severe scorpion enve-
nomation in endemic regions throughout the world, a
standard treatment protocol using drugs and anti-
venom is lacking.
152137 Randomised controlled trials
for treatment of severe scorpion envenomation on
which such guidelines can be based are scarce.
18-21
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